Qu Lin

2.1k total citations
95 papers, 1.6k citations indexed

About

Qu Lin is a scholar working on Hepatology, Cancer Research and Epidemiology. According to data from OpenAlex, Qu Lin has authored 95 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hepatology, 26 papers in Cancer Research and 23 papers in Epidemiology. Recurrent topics in Qu Lin's work include Hepatocellular Carcinoma Treatment and Prognosis (22 papers), Liver Disease Diagnosis and Treatment (14 papers) and Cancer, Lipids, and Metabolism (14 papers). Qu Lin is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (22 papers), Liver Disease Diagnosis and Treatment (14 papers) and Cancer, Lipids, and Metabolism (14 papers). Qu Lin collaborates with scholars based in China and United States. Qu Lin's co-authors include Xing Li, Zhan‐Hong Chen, Min Dong, Xiaokun Ma, Xiangyuan Wu, Dong‐Hao Wu, Mingsheng Huang, Dan‐Yun Ruan, Jing‐Yun Wen and Tiantian Wang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Chemical Engineering Journal.

In The Last Decade

Qu Lin

86 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qu Lin China 24 589 455 416 399 349 95 1.6k
Ciro Romano Italy 22 377 0.6× 266 0.6× 740 1.8× 279 0.7× 211 0.6× 83 1.9k
Shi‐Yi Yang Taiwan 22 522 0.9× 216 0.5× 417 1.0× 366 0.9× 91 0.3× 60 1.6k
Jan‐Show Chu Taiwan 25 991 1.7× 369 0.8× 503 1.2× 199 0.5× 135 0.4× 74 2.0k
Xueping Wang China 23 353 0.6× 267 0.6× 428 1.0× 171 0.4× 128 0.4× 83 1.3k
Cheng Pan China 16 727 1.2× 167 0.4× 470 1.1× 213 0.5× 171 0.5× 71 1.6k
Nan Zhang China 27 728 1.2× 308 0.7× 739 1.8× 587 1.5× 145 0.4× 170 2.4k
Yotaro Kudo Japan 21 966 1.6× 323 0.7× 473 1.1× 276 0.7× 226 0.6× 37 1.9k
Meera Mathur India 28 785 1.3× 367 0.8× 687 1.7× 243 0.6× 73 0.2× 102 2.1k
Sung Pyo Hong South Korea 25 568 1.0× 314 0.7× 221 0.5× 197 0.5× 191 0.5× 114 1.7k
Sheau‐Fang Yang Taiwan 24 523 0.9× 272 0.6× 526 1.3× 158 0.4× 41 0.1× 134 1.7k

Countries citing papers authored by Qu Lin

Since Specialization
Citations

This map shows the geographic impact of Qu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qu Lin more than expected).

Fields of papers citing papers by Qu Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qu Lin. The network helps show where Qu Lin may publish in the future.

Co-authorship network of co-authors of Qu Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Qu Lin. A scholar is included among the top collaborators of Qu Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qu Lin. Qu Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Fen, Shuyu Xiang, Guang Yang, et al.. (2025). Thermal-enhanced deep removal of multiple impurities upon pH induction towards selective regeneration of high-purity iron phosphate. Chemical Engineering Journal. 515. 163476–163476. 1 indexed citations
2.
Ma, Yan, Zengchang Pang, Qu Lin, et al.. (2025). Polygonatum sibiricum Extract Inactivates Cronobacter sakazakii Isolated from Powdered Infant Formula. Foodborne Pathogens and Disease. 23(4). 239–245. 1 indexed citations
3.
Wei, Xiaoxiang, et al.. (2023). Situation analysis and blood transfusion strategy of Lewis antibodies in Hunan Province. Allergologia et Immunopathologia. 51(3). 49–55. 1 indexed citations
4.
5.
Cai, Xiurong, Zhan‐Hong Chen, Xiaoping Zhang, et al.. (2018). Modified CLIP score with the albumin-bilirubin grade retains prognostic value in HBV-related hepatocellular carcinoma patients treated with trans-catheter arterial chemoembolization therapy. Journal of Cancer. 9(13). 2380–2388. 12 indexed citations
6.
7.
Li, Xing, Xiang Zhong, Zhan‐Hong Chen, et al.. (2016). Efficacy of Prophylactic Entecavir for Hepatitis B Virus-Related Hepatocellular Carcinoma Receiving Transcatheter Arterial Chemoembolization. Asian Pacific Journal of Cancer Prevention. 16(18). 8665–8670. 10 indexed citations
8.
9.
Chen, Jie, Qu Lin, Xing Li, et al.. (2014). Prognosis value of mitotic kinase Aurora-A for primary duodenal adenocarcinoma. Tumor Biology. 35(9). 9361–9370. 4 indexed citations
10.
Lin, Qu, Zetao Liao, Qiuxia Li, et al.. (2014). Higher Percentage of CD3+CD154+ T Lymphocytes Predicts Efficacy of TNF-α Inhibitors in Active Axial SpA Patients. Inflammation. 37(6). 2056–2061. 2 indexed citations
11.
Dong, Min, Xinjuan Fan, Zhan‐Hong Chen, et al.. (2014). Aberrant expression of enhancer of zeste homologue 2, correlated with HIF-1α, refines relapse risk and predicts poor outcome for breast cancer. Oncology Reports. 32(3). 1101–1107. 14 indexed citations
12.
Li, Xing, Zhan‐Hong Chen, Xiaokun Ma, et al.. (2014). Neutrophil-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma. Tumor Biology. 35(11). 11057–11063. 35 indexed citations
13.
Dong, Min, Xiang‐Bo Wan, Wei Li, et al.. (2013). Low expression of Beclin 1 and elevated expression of HIF-1α refine distant metastasis risk and predict poor prognosis of ER-positive, HER2-negative breast cancer. Medical Oncology. 30(1). 355–355. 43 indexed citations
14.
Wu, Xiangyuan, Xing Li, Zhan‐Hong Chen, et al.. (2012). An optimized antiviral modification strategy for prevention of hepatitis B reactivation in patients undergoing prophylactic lamivudine and chemotherapy: a pilot study. Tumor Biology. 34(2). 909–918. 7 indexed citations
15.
Li, Xing, Qu Lin, Min Dong, et al.. (2010). Prognostic analysis of acute exacerbations of hepatitis-B after chemotherapy in combination with rituximab in 19 patients with lymphoma. Leukemia & lymphoma. 51(9). 1678–1685. 9 indexed citations
16.
Lin, Qu, Zhiming Lin, Jieruo Gu, et al.. (2009). Abnormal high-expression of CD154 on T lymphocytes of ankylosing spondylitis patients is down-regulated by etanercept treatment. Rheumatology International. 30(3). 317–323. 11 indexed citations
17.
Liu, Jiajun, Renwei Huang, Dong-Jun Lin, et al.. (2006). Antiproliferation effects of oridonin on HPB-ALL cells and its mechanisms of action. American Journal of Hematology. 81(2). 86–94. 20 indexed citations
18.
Liu, Jiajun, Huiling Lü, Renwei Huang, et al.. (2005). Peroxisome proliferator activated receptor-γ ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells. Cancer Chemotherapy and Pharmacology. 56(4). 400–408. 44 indexed citations
19.
Liu, Jiajun, Renwei Huang, Dong-Jun Lin, et al.. (2005). Apoptotic effect of oridonin on NB4 cells and its mechanism. Leukemia & lymphoma. 46(4). 593–597. 13 indexed citations
20.
Huang, Mingsheng, Qu Lin, Zaibo Jiang, et al.. (2004). Comparison of long-term effects between intra-arterially delivered ethanol and Gelfoam for the treatment of severe arterioportal shunt in patients with hepatocellular carcinoma. World Journal of Gastroenterology. 10(6). 825–825. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ciro Romano Breakdown of academic impact, for papers by Shi‐Yi Yang Breakdown of academic impact, for papers by Jan‐Show Chu Breakdown of academic impact, for papers by Xueping Wang Breakdown of academic impact, for papers by Cheng Pan Breakdown of academic impact, for papers by Nan Zhang Breakdown of academic impact, for papers by Yotaro Kudo Breakdown of academic impact, for papers by Meera Mathur Breakdown of academic impact, for papers by Sung Pyo Hong Breakdown of academic impact, for papers by Sheau‐Fang Yang
Rankless by CCL
2026